PureTech Health (NASDAQ:PRTC) Shares Gap Down – Time to Sell?

PureTech Health plc (NASDAQ:PRTCGet Free Report)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $22.15, but opened at $21.00. PureTech Health shares last traded at $21.00, with a volume of 600 shares trading hands.

Wall Street Analyst Weigh In

A number of research firms have weighed in on PRTC. Leerink Partnrs raised shares of PureTech Health to a “strong-buy” rating in a report on Monday, September 9th. Leerink Partners initiated coverage on shares of PureTech Health in a research note on Monday, September 9th. They issued an “outperform” rating and a $45.00 price objective on the stock.

Get Our Latest Analysis on PRTC

PureTech Health Trading Down 3.4 %

The business’s fifty day moving average price is $21.26 and its 200-day moving average price is $22.41.

Institutional Trading of PureTech Health

An institutional investor recently bought a new position in PureTech Health stock. Birch Hill Investment Advisors LLC bought a new stake in shares of PureTech Health plc (NASDAQ:PRTCFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 302,000 shares of the company’s stock, valued at approximately $7,550,000. Birch Hill Investment Advisors LLC owned about 1.26% of PureTech Health as of its most recent SEC filing. 0.04% of the stock is owned by institutional investors and hedge funds.

About PureTech Health

(Get Free Report)

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.

Featured Articles

Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.